Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Europe Drug Delivery Devices Market Size, Share, Growth, Trends and Industry Analysis: By Product Type, By Route of Administration, By Formulation, By Application, By Distribution Channel, and Country Forecast 2021-2032
Europe Drug Delivery Devices Market size was valued at US$ 574.5 billion in 2025 and is expected to reach US$ 953.1 billion by 2032, growing at a significant CAGR of 7.5% from 2026-2032. Drug delivery devices are used to deliver the drugs or chemical substances into the body for therapeutic effects by using different formulations, technologies, and approaches. These devices can be used for diagnosis, treatment, cure, or prevent various diseases such as diabetes, autoimmune disorders, bacterial and viral infections, and allergies among others. Various medicinal formulations such as antibiotics and insulin are most commonly administered by using these devices to increase the efficiency of drug by controlling dosage, time, and release the drug at specific site in the body.
Study Period
2026-2032Base Year
2025CAGR
7.5%Largest Market
N/AFastest Growing Market
N/A
Increase in the prevalence of chronic diseases such as diabetes and cancer due to change in lifestyle Rise in R&D activities for the innovation of newer devices Rise in demand for customized therapy and better availability of the products Restraints: Stringent regulation for the approval of drug delivery devices Product recalls and Complications in the use of drug delivery devices such as dosage errors High cost of drug delivery devices
|
Report Benchmarks |
Details |
|
Report Study Period |
2026-2032 |
|
Market CAGR |
7.5% |
|
By Product Type |
|
|
By Route Administration |
|
|
By Formulation Type |
|
|
By Distribution Channel |
|
Download Free Sample Report
Europe drug delivery devices market size was valued at US$ 534.41 billion in 2024 and is projected to grow at a significant CAGR of 7.5% from 2025-2031.
The market report covers are the Germany, France, Italy, Spain, and United Kingdom (UK)
The market key players are Becton Dickinson and Company, Hoffmann La Roche Ltd., Smiths medical, Inc., Braun Melsungen AG, Pfizer, Inc., Merck & Co., Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, Eli Lilly and company, AptarGroup, Inc.
Content Updated Date: Jan 2026
| 1.Executive Summary |
| 2.Europe Drug Delivery Devices Market Introduction |
| 2.1.Europe Drug Delivery Devices Market - Taxonomy |
| 2.2.Europe Drug Delivery Devices Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Route Administration |
| 2.2.3.Formulation Type |
| 2.2.4.Distribution Channel |
| 2.2.5.Country |
| 3.Europe Drug Delivery Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Europe Drug Delivery Devices Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Europe Drug Delivery Devices Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Infusion Pumps |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Metered Dose Inhalers |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nebulizers |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Syringes |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Ocular Inserts |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Nasal Sprays |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Implantable Drug Delivery Devices |
| 5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Transdermal Patches |
| 5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Trans-Mucosal Drug Delivery Devices |
| 5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Others |
| 5.10.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 6.Europe Drug Delivery Devices Market By Route Administration, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Parenteral |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Transdermal |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Trans-Mucosal |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Inhalation |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Ocular |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Europe Drug Delivery Devices Market By Formulation Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Solid |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Liquid |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Semi-solid |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Europe Drug Delivery Devices Market By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9.Europe Drug Delivery Devices Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Germany |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. France |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Italy |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. United Kingdom (UK) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Spain |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.Germany Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Infusion Pumps |
| 10.1.2.Metered Dose Inhalers |
| 10.1.3.Nebulizers |
| 10.1.4.Syringes |
| 10.1.5.Ocular Inserts |
| 10.1.6.Nasal Sprays |
| 10.1.7.Implantable Drug Delivery Devices |
| 10.1.8.Transdermal Patches |
| 10.1.9.Trans-Mucosal Drug Delivery Devices |
| 10.1.10.Others |
| 10.2. Route Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral |
| 10.2.2.Parenteral |
| 10.2.3.Transdermal |
| 10.2.4.Trans-Mucosal |
| 10.2.5.Inhalation |
| 10.2.6.Ocular |
| 10.2.7.Others |
| 10.3. Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Solid |
| 10.3.2.Liquid |
| 10.3.3.Semi-solid |
| 10.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospital Pharmacies |
| 10.4.2.Retail Pharmacies |
| 10.4.3.Online Pharmacies |
| 10.4.4.Others |
| 11.France Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Infusion Pumps |
| 11.1.2.Metered Dose Inhalers |
| 11.1.3.Nebulizers |
| 11.1.4.Syringes |
| 11.1.5.Ocular Inserts |
| 11.1.6.Nasal Sprays |
| 11.1.7.Implantable Drug Delivery Devices |
| 11.1.8.Transdermal Patches |
| 11.1.9.Trans-Mucosal Drug Delivery Devices |
| 11.1.10.Others |
| 11.2. Route Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral |
| 11.2.2.Parenteral |
| 11.2.3.Transdermal |
| 11.2.4.Trans-Mucosal |
| 11.2.5.Inhalation |
| 11.2.6.Ocular |
| 11.2.7.Others |
| 11.3. Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Solid |
| 11.3.2.Liquid |
| 11.3.3.Semi-solid |
| 11.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospital Pharmacies |
| 11.4.2.Retail Pharmacies |
| 11.4.3.Online Pharmacies |
| 11.4.4.Others |
| 12.Italy Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Infusion Pumps |
| 12.1.2.Metered Dose Inhalers |
| 12.1.3.Nebulizers |
| 12.1.4.Syringes |
| 12.1.5.Ocular Inserts |
| 12.1.6.Nasal Sprays |
| 12.1.7.Implantable Drug Delivery Devices |
| 12.1.8.Transdermal Patches |
| 12.1.9.Trans-Mucosal Drug Delivery Devices |
| 12.1.10.Others |
| 12.2. Route Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral |
| 12.2.2.Parenteral |
| 12.2.3.Transdermal |
| 12.2.4.Trans-Mucosal |
| 12.2.5.Inhalation |
| 12.2.6.Ocular |
| 12.2.7.Others |
| 12.3. Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Solid |
| 12.3.2.Liquid |
| 12.3.3.Semi-solid |
| 12.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospital Pharmacies |
| 12.4.2.Retail Pharmacies |
| 12.4.3.Online Pharmacies |
| 12.4.4.Others |
| 13.United Kingdom (UK) Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Infusion Pumps |
| 13.1.2.Metered Dose Inhalers |
| 13.1.3.Nebulizers |
| 13.1.4.Syringes |
| 13.1.5.Ocular Inserts |
| 13.1.6.Nasal Sprays |
| 13.1.7.Implantable Drug Delivery Devices |
| 13.1.8.Transdermal Patches |
| 13.1.9.Trans-Mucosal Drug Delivery Devices |
| 13.1.10.Others |
| 13.2. Route Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral |
| 13.2.2.Parenteral |
| 13.2.3.Transdermal |
| 13.2.4.Trans-Mucosal |
| 13.2.5.Inhalation |
| 13.2.6.Ocular |
| 13.2.7.Others |
| 13.3. Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Solid |
| 13.3.2.Liquid |
| 13.3.3.Semi-solid |
| 13.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospital Pharmacies |
| 13.4.2.Retail Pharmacies |
| 13.4.3.Online Pharmacies |
| 13.4.4.Others |
| 14.Spain Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Infusion Pumps |
| 14.1.2.Metered Dose Inhalers |
| 14.1.3.Nebulizers |
| 14.1.4.Syringes |
| 14.1.5.Ocular Inserts |
| 14.1.6.Nasal Sprays |
| 14.1.7.Implantable Drug Delivery Devices |
| 14.1.8.Transdermal Patches |
| 14.1.9.Trans-Mucosal Drug Delivery Devices |
| 14.1.10.Others |
| 14.2. Route Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Oral |
| 14.2.2.Parenteral |
| 14.2.3.Transdermal |
| 14.2.4.Trans-Mucosal |
| 14.2.5.Inhalation |
| 14.2.6.Ocular |
| 14.2.7.Others |
| 14.3. Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Solid |
| 14.3.2.Liquid |
| 14.3.3.Semi-solid |
| 14.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospital Pharmacies |
| 14.4.2.Retail Pharmacies |
| 14.4.3.Online Pharmacies |
| 14.4.4.Others |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Becton Dickinson and Company |
| 15.2.2.Hoffmann La Roche Ltd. |
| 15.2.3.Smiths medical, Inc. |
| 15.2.4.Braun Melsungen AG |
| 15.2.5.Pfizer, Inc. |
| 15.2.6.Merck & Co., Inc. |
| 15.2.7.Sanofi S.A. |
| 15.2.8.Abbott Laboratories |
| 15.2.9.Novartis AG |
| 15.2.10.Eli Lilly and company |
| 15.2.11.AptarGroup, Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players